MedTrace Logo

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

NCT01619241 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2012-06-14

No results posted yet for this study

Summary

The objective of this pilot study is to determine whether 18F-FLT PET/CT can predict which patients will have poorer progression free survival and overall survival in advanced Non-small Cell Lung Cancer (NSCLC) after first-line therapy and, therefore, need more aggressive treatment.

Conditions

Interventions

OTHER

PET/CT

F-18 FLT PET/CT

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Principal Investigators

  • Ie Ryung Yoo, MD · Seoul St. Mary's Hospital

  • Jin Hyoung Kang, MD, PhD · Seoul St. Mary's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-08-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01619241 on ClinicalTrials.gov